GlassScriptPhysician profile
Joel Rosenberg
NPI 1356920458
$4,155.79
in general payments reported to CMS, 2019-2025
16 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $414 · 2023: $468 · 2024: $2,256 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,239 · Education: $1,125 · Honoraria: $224 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,238.54 |
| Education | $1,125.00 |
| Honoraria | $224.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,316.84 | 2022-2024 | |
| Boston Scientific Corporation | $776.22 | 2022-2025 | Lithovue, General - Kidney Stone Disease, Ams 700 |
| Coloplast Corp | $650.81 | 2023-2025 | Restorelle, Saffron, Titan |
| Teleflex LLC | $327.74 | 2023-2025 | Urolift, Barrigel |
| Medtronic, INC. | $249.80 | 2021-2024 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $236.00 | 2024 | |
| Calyxo, INC. | $135.97 | 2024 | Cvac Aspiration System |
| Janssen Biotech, INC. | $126.39 | 2025 | Rybrevant, Carvykti |
| Sumitomo Pharma America, INC. | $125.00 | 2025 | Orgovyx |
| Baxter Healthcare | $56.46 | 2023-2025 | Seprafilm, Tisseel |
| Procept Biorobotics Corporation | $49.26 | 2024-2025 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $23.54 | 2024 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $23.10 | 2023 | |
| Travere Therapeutics, INC. | $22.53 | 2022 | |
| Novo Nordisk INC | $21.13 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.